Loraderm

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Loraderm

Property Description
Active ingredient Loratadine
Form Tablet, Oral Syrup, Capsule
Pharmacological class Second-Generation Antihistamine
General Purpose Symptomatic relief for allergic conditions
Origin Synthetic, Tricyclic Compound

1. Identity and Classification: What Type of Medicine is Loraderm?

Loraderm is a pharmaceutical preparation that utilizes the active ingredient Loratadine (INN), a substance classified as a second-generation antihistamine. This compound is a synthetic derivative of the tricyclic piperidine chemical structure. Loratadine functions as a highly selective antagonist of peripheral H1 receptors.

This classification within the second-generation group relates to its characteristic to minimally penetrate the blood-brain barrier. This molecular characteristic is clinically recognized for contributing to a significantly reduced potential for somnolence or sedation when compared to the older first-generation agents. Loraderm, like its common formulation equivalent, is widely recognized as an accessible non-prescription (OTC) choice in many regulatory regions.


2. Loraderm's General Purpose and Mechanism Principle

The core general purpose of Loraderm is to provide systemic relief from the symptoms caused by the body’s allergic responses, such as sneezing, watery eyes, and itching, often triggered by environmental factors. It achieves this benefit through the principle of histamine blockade—it prevents histamine, a chemical released during an immune reaction, from binding to its specific receptor sites on cells.

By blocking the activation of peripheral H1 receptors, Loratadine effectively interrupts the physiological events that lead to typical allergic discomfort. The medication provides symptomatic relief for allergic reactions and is utilized to minimize the disruptive discomfort associated with hypersensitivity reactions while maintaining a non-sedating and long-acting profile.


3. Available Forms and Core Composition

The medicinal preparation containing Loratadine is formulated for oral administration, meaning it is taken by mouth, and is commonly available in several forms, including the standard tablet, as well as an oral syrup and capsule. The syrup form, often marketed for pediatric and adult patients who prefer liquids, allows for flexible and convenient administration.

The composition of Loraderm is focused on the single active ingredient, Loratadine. It is typically classified as a single-active-ingredient product, and the active drug is combined with inert ingredients—known as excipients—such as stabilizing agents for the liquid forms or pharmaceutical bases for the solid tablets.

Regulatory References

  1. Loratadine - StatPearls

What side effects are possible with Loraderm?

Possible Side Effects and Safety Information

The safety profile of Loraderm, which contains Loratadine, is officially classified by frequency and grouped into distinct physiological systems as documented in regulatory sources such as the EMA Summary of Product Characteristics (SmPC) and the FDA Prescribing Information. This non-sedating profile is established by classifying adverse reactions into categories like Common, Very Rare, and Not Known.


Frequency-Classified Adverse Reactions

The most frequently reported effects, classified as Common in adults and adolescents, include headache, somnolence (drowsiness), insomnia, and increased appetite. For children aged 2 to 12 years, headache, nervousness, and fatigue are commonly reported.

Serious Adverse Reactions and Systemic Effects

Adverse reactions classified as Very Rare are documented across several System-Organ Classes. These include cardiac disorders (e.g., tachycardia, palpitation), gastrointestinal disorders (e.g., nausea, dry mouth), and serious reactions such as abnormal hepatic function and convulsion. The most critical, though rare, reports are severe hypersensitivity reactions, including anaphylaxis and angioedema.


Population-Specific Safety Notes

The official labeling defines specific safety considerations for certain populations. Caution is required in patients with severe hepatic impairment, as reduced clearance may necessitate an adjustment to the initial dose. Furthermore, use is generally not recommended during breast-feeding because the substance is known to be excreted in breast milk. Safety and efficacy of the tablet formulation have not been established in children under two years of age.

Safety-Related Restrictions

Loraderm is formally contraindicated for individuals with known hypersensitivity to Loratadine. Additionally, to avoid interference with results, the medicine must be discontinued at least 48 hours prior to skin allergy testing.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documents specify the clinical profile and mandated response for an overdose of the active ingredient in Loraderm (Loratadine).

Documented Manifestations

Overdose in adults has been documented to present primarily with somnolence (drowsiness), tachycardia (rapid heartbeat), and headache. In children, exposure to supratherapeutic doses, particularly of the oral syrup, has resulted in reports of extrapyramidal signs and palpitations. An increased occurrence of anticholinergic symptoms is also noted in the regulatory overdose classification.

Emergency Actions and Required Management

Immediate medical attention is necessary if an overdose is suspected. Regulatory information instructs users to seek immediate medical attention or contact a Poison Control Center right away.

Urgent action is required—specifically calling emergency services (911)—if the affected individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Management procedures focus on general symptomatic and supportive measures. The official labeling states that no specific antidote is known. Measures that may be considered by medical professionals include gastric lavage and the administration of activated charcoal to limit absorption. It is also noted that the active ingredient is not eliminated by haemodialysis.

Therapeutic Uses of Loraderm

What Loraderm Treats: Main Uses and Benefits

Loraderm is commonly used in conditions characterized by periods of heightened symptoms associated with seasonal and perennial allergies. It generally helps address symptom clusters that may create noticeable interference with daily stability, such as persistent sneezing, runny nose, nasal itching, and irritating watery eyes. The medication is also relevant in conditions marked by increased discomfort due to allergic skin reactions, notably in managing the intense pruritus (itching) and the emergence of wheals (hives) associated with urticaria.

This application plays a role in managing symptoms that helps patients cope more steadily with these symptoms related to physical discomfort. The medicine is commonly used for managing symptoms of allergic rhinitis (hay fever), hives, and other allergic skin manifestations. Loraderm generally assists with supportive relief when symptoms become temporarily overwhelming.

“This application supports the patient in maintaining functional stability and alertness.”

This support helps to ease the overall symptom burden on daily life and contributes to improved comfort during symptomatic periods.


Quick Fact: Supports Management of Nasal/Ocular Symptoms and Skin Pruritus

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Loraderm?

This section outlines the officially documented population eligibility rules for Loraderm (Loratadine) as defined by regulatory authorities.


Eligibility Classification Population Restriction
Absolute Contraindication Patients with known hypersensitivity or allergy to loratadine or any component of the specific formulation.
Contraindication (Formulation-Specific) Patients with Phenylketonuria (PKU) if using formulations containing aspartame.

Age-Related Eligibility and Restrictions

Use is approved and established for adults and adolescents 12 years of age and older, and for most children aged 2 to 11 years. However, the safety and efficacy have not been established for children younger than 2 years of age, and use in this group is not recommended by regulatory agencies. For certain tablet forms, use is generally restricted to children weighing over 30 kg.

Conditional Use and Restricted Eligibility

  • Severe Organ Impairment: Patients with severe hepatic impairment or severe renal insufficiency (Glomerular Filtration Rate < 30 mL/min) are subject to conditional use as clearance of the medicine may be reduced. Regulators typically advise an initial dose adjustment in these populations.
  • Pregnancy and Lactation: Use of Loraderm is not recommended during pregnancy or breastfeeding. This is advised as a precautionary measure because the medicine is known to be excreted into human breast milk.

What should I know about interactions with other medicines?

The potential for drug-drug interactions with this topical combination product arises from the systemic absorption of its two active components: the corticosteroid (betamethasone) and the antifungal agent (clotrimazole). The extent of systemic absorption is variable and increases with prolonged use, application to large surface areas, and use under occlusive dressings.

Documented Interaction Mechanisms

  • Corticosteroid Component (Betamethasone): The systemic effects of absorbed betamethasone may interact with other medicines. Concomitant use with Quinolone Antibiotics (e.g., ciprofloxacin) may increase the risk of tendon rupture. Combination with Neuromuscular Blockers (e.g., atracurium, cisatracurium) can increase the risk of acute myopathy. Immunosuppressive effects may reduce the expected response to Vaccines (e.g., cholera vaccine). The corticosteroid may also interfere with the results of certain diagnostic tests, such as the cosyntropin injection test.

  • Antifungal Component (Clotrimazole): Clotrimazole is a known inhibitor of the Cytochrome P450 3A4 (CYP3A4) enzyme. While systemic absorption is minimal, this property has the potential to increase the plasma concentration of co-administered medicines that are metabolized by CYP3A4, such as certain Erectile Dysfunction Medications (e.g., avanafil) and Cannabidiol. Dosage adjustments for these interacting agents may be necessary.

Other Topical Product Constraints

Co-application of this product with other Topical Acne Drugs may increase local skin irritation or dryness. Avoiding co-administration unless directed by a healthcare professional is advisable. Patients should inform their doctor of all medicines, supplements, and skin products used.

Mechanism of Action

Selective Histamine H1 Receptor Antagonism

Loraderm, containing loratadine, primarily functions as a long-acting, selective inverse agonist of peripheral Histamine H1 receptors. The drug and its active metabolite, desloratadine, engage these receptors on cells like endothelial cells and smooth muscle, stabilizing their inactive conformation. This critical binding action blocks the effects of endogenously released histamine, reducing downstream signal transduction through the H1 receptor. This molecular interaction results in a fundamental modulation of receptor-mediated signal output.


️ Modulation of Inflammatory Mediator Release

The second mechanistic domain involves modulating inflammatory pathways, distinct from H1 antagonism. At concentrations achievable within tissues, loratadine engages processes that regulate cellular activation, specifically by inhibiting the release of histamine and other inflammatory compounds, such as leukotrienes, from mast cells and basophils. This downstream effect alters baseline pathway activity within targeted inflammatory cascades, acting in addition to the primary receptor-blocking mechanism.

Dosage and Administration Information

How to use Loraderm

Loraderm (Loratadine) is officially administered via the oral route, meaning it is taken by mouth. The medicine is commonly available in a 10 mg tablet strength and a 5 mg/5 mL oral solution. The standard use pattern across all approved indications is based on a once-daily frequency, which aligns with its long duration of action. Tablets and liquid forms may be taken without regard to mealtime, providing flexibility in scheduling the daily dose.

The official dosing regimen is stratified by age to ensure appropriate administration:

Patient Population Standard Daily Dose Frequency
Adults and Adolescents (12 years and older) 10 mg Once Daily
Children (6 to 11 years) 10 mg Once Daily
Children (2 to under 6 years) 5 mg Once Daily

For populations with severely reduced drug clearance, specifically those with severe hepatic impairment or severe renal impairment (GFR <30 mL/min), a mandatory adjustment to the dosing interval is required. In these circumstances, the official recommended dose is administered every other day instead of daily to prevent drug accumulation. Additionally, to maintain diagnostic integrity, labels advise that the use of Loraderm must be discontinued at least 48 hours prior to any scheduled skin allergy testing.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Loraderm

Research Evidence for Use in Seasonal and Perennial Allergic Rhinitis (Hay Fever)

Research has primarily consisted of studies exploring conditions characterized by fluctuating or episodic manifestations of seasonal and perennial allergic rhinitis. These trials, primarily randomized controlled trials, were used to track symptom patterns over defined time intervals. Researchers focused on measuring key outcomes related to systemic or functional imbalance, such as scores for nasal and ocular symptoms. Research so far indicates that studies focusing on episodes where symptoms become more noticeable reported measured changes in Total Symptom Scores (TSS) and measured changes in allergy-specific Quality of Life (QoL) measures. Specialized studies were also used to record the time to onset of any measured change.

Research Evidence for Use in Chronic Urticaria (Hives)

For conditions involving periods of heightened symptoms such as chronic urticaria, research has studied Loraderm in randomized, placebo-controlled trials. The main outcomes related to physical discomfort that were measured included the intensity of pruritus (itching) and changes in the number and size of visible wheals (hives). Studies reported measurements showing changes in scores assigned to itching and wheal size following administration. Findings describe patterns observed in the studies related to the management of these outcomes linked to inflammatory or irritative states.

What is Still Uncertain About Loraderm's Research Base

Studies conducted during periods of increased symptom activity have typically involved short follow-up durations, meaning certainty remains low regarding long-term effects for continuous use in the general adult and adolescent population. The evidence base also has limited information for long-term outcomes for continuous use in the pediatric population, particularly for children aged 2 to 12 years. Additionally, comparative evidence is lacking in some study designs when examining Loraderm against all relevant second-generation options in severe or refractory cases of chronic urticaria.

Frequently Asked Questions (FAQ)

Common questions about Loraderm (FAQ)

Q: How long does Loraderm take to start working?

Studies and official product information indicate that the medicine begins to exhibit an antihistaminic effect generally within 1 to 3 hours after administration. The measured effect typically reaches its maximum at approximately 8 to 12 hours.


Q: Do I need a prescription to get Loraderm?

In many regulatory regions, including the United States, Loraderm (loratadine) is classified as an over-the-counter (OTC) medication. This means the medicine can be obtained without a prescription from a healthcare professional.


Q: What happens if I forget to use Loraderm?

Official guidance on managing missed doses recommends taking the dose as soon as you remember it. If it is almost time for your next scheduled dose, the protocol advises that the missed dose is skipped to prevent taking a double dose.


Q: How long can a person usually use Loraderm?

Regulatory documents from some regions describe the use of this medicine for adults and children over 12 years of age for up to 6 months. Using the medication for a period longer than this is a topic for discussion with a healthcare provider.


Q: Does Loraderm interact with vitamins or supplements?

Information regarding potential interactions with herbal remedies and dietary supplements is generally limited in official sources. Official health resources note that products causing side effects such as sleepiness or dry mouth may present a concern when used alongside Loraderm.


Q: Are there any specific foods or drinks I should avoid while using Loraderm?

The official product label indicates that taking the medication with food does not affect the plasma concentrations of the drug. Therefore, the dose may be taken without regard to mealtime.


Q: Do I have to change my routine when I start using Loraderm?

Regulatory information advises that the medicine must be discontinued at least 48 hours prior to any scheduled skin allergy testing to avoid interference with the results. Additionally, the regulatory label advises caution regarding activities like driving or operating machinery because the medicine may affect coordination.


Q: Can Loraderm affect my mood or sleep?

Official regulatory documents list several effects related to the central nervous system. Reported adverse reactions include somnolence (drowsiness), insomnia, and nervousness.


Q: What is the difference between a minor and a serious side effect of Loraderm?

The safety profile classifies adverse reactions by frequency, such as Common or Very Rare. Serious adverse reactions are typically defined as those that may involve systemic effects like abnormal hepatic function or severe allergic reactions such as anaphylaxis, which are considered critical and should be promptly reported to a healthcare provider.


Q: Why do some people say Loraderm makes them feel tired?

Official information lists somnolence (drowsiness) and fatigue as reported adverse reactions. Official information suggests this occurs because the drug, though a second-generation type, may still cross the protective blood-brain barrier to a minimal extent in some individuals.


Q: Can I use Loraderm if I have a history of allergies?

Regulatory information states that this medicine is contraindicated only for individuals with a known hypersensitivity or allergy to loratadine itself or to any of the components of the formulation. A general history of other allergies is not listed as an absolute contraindication.


Q: Does Loraderm help with inflammation?

The official mechanism of action includes two domains. The second domain involves the modulation of inflammatory mediator release, which works by engaging processes that help regulate the release of certain inflammatory compounds, such as leukotrienes and histamine, from cells.


Q: Is there a generic version of Loraderm available?

Loratadine, the active ingredient in Loraderm, is classified in many regulatory regions as an available generic medication.


Q: What kind of doctor usually prescribes Loraderm?

In many regions, the medicine is classified as an Over-the-Counter (OTC) product and does not require a prescription. If a prescription is required, it is typically managed by a primary care provider or a specialist such as an allergist.


Q: How is the safety of Loraderm monitored after it is released to the public?

Regulatory bodies maintain systems for postmarket surveillance to continuously monitor the safety of medications after they have been released to the public. These systems collect and analyze reports of unforeseen or anticipated adverse events.


Q: Can using Loraderm cause weight changes?

Official regulatory documents list increased appetite as a commonly reported adverse reaction in adults and adolescents. The product information does not explicitly state that the medicine causes weight change.


Q: Does the time of day matter when using Loraderm?

The medicine has a long duration of action and is officially administered based on a once-daily frequency. The medicine is effective when taken once-daily and may be taken without regard to mealtime.


Q: What is the typical expectation for improvement when starting Loraderm?

Studies indicate that an antihistaminic effect generally begins within 1 to 3 hours after administration. The measured effect typically reaches its maximum benefit within 8 to 12 hours, which supports the finding that the medicine provides effective symptomatic relief.


Q: Are there special patient groups where Loraderm is used with extra caution?

Regulatory information defines specific populations where use requires caution. These include patients with severe hepatic impairment and severe renal insufficiency (kidney disease), as well as geriatric patients, due to potential for decreased organ function and increased risk of somnolence.

How should Loraderm be stored and disposed of?

How to Store and Dispose of Loraderm

Loraderm (loratadine) must be stored under specific environmental conditions to maintain stability and effectiveness.


Storage Requirements

The product must be stored at Controlled Room Temperature, defined as 20^\circC to 25^\circC (68^\circF to 77^\circF), with permitted excursions up to 30^\circC (86^\circF). The medication must be protected from excessive moisture and kept in its original packaging.

Specific liquid forms must be protected from freezing.


Child Safety and Disposal

All forms of Loraderm must be stored out of reach of children.

For disposal of unused or expired medication, Loraderm is a "non-flush list" medicine. Disposal should follow the procedures for household trash (mixing the medicine with an undesirable substance like dirt or used coffee grounds) or utilize official community drug take-back programs, which are the preferred method for discarding unused product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Loraderm found in:

A-Z Index: